Xcel Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,460
Closed -$478K 135
2025
Q4
$478K Hold
1,460
0.12% 103
2025
Q3
$412K Hold
1,460
0.11% 104
2025
Q2
$408K Hold
1,460
0.12% 101
2025
Q1
$455K Hold
1,460
0.14% 96
2024
Q4
$381K Hold
1,460
0.11% 98
2024
Q3
$470K Hold
1,460
0.14% 86
2024
Q2
$456K Hold
1,460
0.14% 85
2024
Q1
$415K Hold
1,460
0.13% 89
2023
Q4
$421K Sell
1,460
-50
-3% -$13.6K 0.15% 84
2023
Q3
$406K Sell
1,510
-5,736
-79% -$1.43M 0.16% 83
2023
Q2
$1.61M Buy
7,246
+41
+0.6% +$9.51K 0.51% 50
2023
Q1
$1.74M Buy
7,205
+40
+0.6% +$9.82K 0.61% 47
2022
Q4
$1.88M Sell
7,165
-73
-1% -$19.6K 0.74% 41
2022
Q3
$1.63M Buy
7,238
+33
+0.5% +$8K 0.61% 46
2022
Q2
$1.75M Sell
7,205
-866
-11% -$212K 0.64% 46
2022
Q1
$1.95M Sell
8,071
-2,723
-25% -$626K 0.54% 54
2021
Q4
$2.43M Buy
10,794
+65
+0.6% +$13.7K 0.62% 50
2021
Q3
$2.28M Buy
10,729
+32
+0.3% +$7.37K 0.66% 45
2021
Q2
$2.61M Sell
10,697
-207
-2% -$50.9K 0.79% 37
2021
Q1
$2.71M Buy
10,904
+52
+0.5% +$12.4K 0.97% 32
2020
Q4
$2.5M Sell
10,852
-45
-0.4% -$10.4K 1.08% 30
2020
Q3
$2.77M Sell
10,897
-700
-6% -$173K 1.42% 24
2020
Q2
$2.73M Sell
11,597
-300
-3% -$68.4K 1.7% 20
2020
Q1
$2.41M Sell
11,897
-1,000
-8% -$218K 2.17% 16
2019
Q4
$3.11M Sell
12,897
-335
-3% -$73.8K 2.58% 14
2019
Q3
$2.56M Sell
13,232
-2,150
-14% -$413K 2.37% 14
2019
Q2
$2.83M Buy
15,382
+1,045
+7% +$187K 2.78% 12
2019
Q1
$2.72M Sell
14,337
-1,315
-8% -$251K 2.81% 11
2018
Q4
$3.05M Buy
+15,652
New +$3.05M 3.73% 8

Other funds holding AMGN

Xcel Wealth Management's AMGN Position: Q1 2026 in Review

Xcel Wealth Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,460 shares — an estimated $478K sold.

Xcel Wealth Management first reported a position in AMGN in Q4 2018 and held it in 29 quarters. The position peaked at $3.11M in Q4 2019. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Xcel Wealth Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Xcel Wealth Management sold 1,460 Amgen shares in Q1 2026, an estimated $478K.
  • Xcel Wealth Management first reported a position in Amgen in Q4 2018 and held it in 29 quarters.
  • Xcel Wealth Management's Amgen position peaked at $3.11M in Q4 2019.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Xcel Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.